Palvella Therapeutics
Develops topical QTORIN candidates for serious rare skin diseases and vascular malformations.
$149.97
After-hours close0.00 (0.00%)
At close$149.97(−0.24%)
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| Nov 2026 | −$1.77 | — | — |
| Aug 2026 | −$1.17 | −$1.52 | −29.9% |
| May 2026 | −$0.90 | −$1.20 | −33.3% |
| Mar 2026 | −$0.91 | −$1.08 | −18.5% |
| Nov 2025 | −$0.85 | −$1.03 | −21.2% |
The latest year is open to everyone — the 10 quarters behind it read with an account. Sign in | |||
| Aug 2025 | |||
| May 2025 | |||
| Mar 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Mar 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise |
|---|---|---|---|---|---|---|
| Nov 10, 2026 | −$1.77 | — | — | $16.7K | — | — |
| Aug 4, 2026 | −$1.17 | −$1.52 | −29.9% | — | — | — |
| May 7, 2026 | −$0.90 | −$1.20 | −33.3% | — | — | — |
| Mar 31, 2026 | −$0.91 | −$1.08 | −18.5% | — | — | — |
| Nov 11, 2025 | −$0.85 | −$1.03 | −21.2% | — | — | — |
The latest year is open to everyone — the 10 quarters behind it read with an account. Sign in | ||||||
| Aug 14, 2025 | ||||||
| May 15, 2025 | ||||||
| Mar 31, 2025 | ||||||
| Nov 13, 2024 | ||||||
| Aug 14, 2024 | ||||||
| May 16, 2024 | ||||||
| Mar 30, 2024 | ||||||
| Nov 15, 2023 | ||||||
| Aug 11, 2023 | ||||||
| May 11, 2023 | ||||||